EZH2-specific microRNA-98 inhibits human ovarian cancer stem cell proliferation via regulating the pRb-E2F pathway

• DOI: 10.1007/s13277-014-1950-9
• Publication Date: 2014-04-26T08:11:02Z
• Authors: Te Liu; Lengchen Hou; Yongyi Huang
• Keywords: Adult; Oncogene Proteins; Ovarian Neoplasms; 0303 health sciences; G1 Phase; Polycomb Repressive Complex 2; Middle Aged; Retinoblastoma Protein; E2F Transcription Factors; 3. Good health; DNA-Binding Proteins; Mice; MicroRNAs; 03 medical and health sciences; Cyclin E; Neoplastic Stem Cells; Animals; Heterografts; Humans; Enhancer of Zeste Homolog 2 Protein; Female; Cell Proliferation; Signal Transduction

The Polycomb group protein, enhancer of zeste homolog 2 (EZH2), plays an important role in transcriptional regulation through chromatin remodeling and interactions with other transcription factors to control cell proliferation and embryonic development. Previous study has shown that EZH2 is important for cell cycle regulation and is highly expressed in human ovarian cancer. Loss of EZH2 inhibits growth of ovarian cancer as well as other human carcinomas. In this study, an expression plasmid of EZH2-targeted microRNA-98 was constructed and transfected into human ovarian cancer stem cells (OCSCs). Seventy-two hours after transfection, cell growth was inhibited and arrested at the G0/G1 transition. p21(CIPI/WAF1) was up-regulated, while the CDK2/cyclin E complex and c-Myc were down-regulated. Most importantly, expression levels of E2F1, retinoblastoma protein (pRb), and histone deacetylase 1 (HDAC1) in the pRb-E2F signaling pathway had changed. Furthermore, microRNA-98 suppressed the growth of OCSCs xenograft tumors. Our findings suggest that EZH2-specific microRNA-98 can effectively inhibit cell proliferation in vitro and regulate the pRb-E2F pathway in human OCSCs.